methacholine chloride
Drug data last refreshed 19h ago · AI intelligence enriched 1mo ago
PROVOCHOLINE (methacholine chloride) is a diagnostic agent administered via inhalation to assess airway hyperresponsiveness in patients suspected of having asthma or other obstructive airway diseases. It works as a bronchoconstrictor, causing temporary airway narrowing that helps clinicians identify abnormal airway reactivity. This is a diagnostic tool rather than a therapeutic agent.
As an older diagnostic agent approaching loss of exclusivity with moderate competitive pressure, this product likely operates with a lean, established commercial team focused on retention rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence Study of Methacholine Chloride
A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma
Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma
Working on PROVOCHOLINE offers limited career growth given the product's mature stage, approaching loss of exclusivity, and minimal linked job openings (0 reported). This is a maintenance role best suited for professionals seeking stability in a niche diagnostic market rather than high-growth opportunity.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo